Olympiad Research LP Lowers Stake in Amedisys, Inc. (NASDAQ:AMED)

Olympiad Research LP lessened its position in shares of Amedisys, Inc. (NASDAQ:AMED) by 72.0% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,865 shares of the health services provider’s stock after selling 15,077 shares during the quarter. Olympiad Research LP’s holdings in Amedisys were worth $532,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. National Bank of Canada FI grew its position in Amedisys by 119.0% during the third quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider’s stock valued at $5,365,000 after acquiring an additional 30,213 shares during the period. ABC Arbitrage SA purchased a new stake in Amedisys during the fourth quarter valued at about $2,522,000. Geode Capital Management LLC grew its position in Amedisys by 1.3% during the third quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock valued at $54,746,000 after acquiring an additional 7,071 shares during the period. Quarry LP purchased a new stake in Amedisys during the third quarter valued at about $2,569,000. Finally, Charles Schwab Investment Management Inc. grew its position in Amedisys by 2.7% during the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock valued at $33,400,000 after acquiring an additional 9,004 shares during the period. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Stephens reissued an “equal weight” rating and set a $101.00 price target on shares of Amedisys in a research report on Wednesday, February 12th. Five research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $100.75.

Amedisys Trading Down 0.7 %

Shares of AMED opened at $90.43 on Friday. The stock’s 50-day moving average is $90.74 and its two-hundred day moving average is $93.40. The stock has a market cap of $2.96 billion, a PE ratio of 35.88, a P/E/G ratio of 1.80 and a beta of 0.73. Amedisys, Inc. has a 12 month low of $82.15 and a 12 month high of $98.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.